BioStock: Focus on company split for Respiratorius during Q4

Lund-based Respiratorius is currently undergoing an extensive transformation where the company’s two development projects are being separated. That process set the tone for the company’s report for the fourth quarter of the fiscal year 2021/2022, which this time included four months, instead of the customary three. BioStock contacted Respiratorius’ CEO Johan Drott to find out more about what is going during this transformative time for the company.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/05/focus-on-company-split-for-respiratorius-during-q4/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se